Sitara-D 50/5 Tablet
Marketer
Intas Pharmaceuticals Ltd
Salt Composition
Dapagliflozin (5mg) + Sitagliptin (50mg)
Overview Sitara-D 50/5 Tablet
DiaBeta-Duo 50/5mg tablets combine medications to effectively manage blood glucose. This dual-action therapy, used alongside diet and exercise, improves glycemic control in adults with type 2 diabetes. It enhances insulin efficiency, resulting in reduced blood sugar. DiaBeta-Duo 50/5mg can be administered with or without food, consistently at the same time daily, as directed by your physician. Discontinuing treatment without consulting your doctor may lead to elevated blood sugar, increasing the risk of severe complications such as renal impairment and vision loss. This medication forms part of a comprehensive treatment plan, which necessitates a healthy diet, regular physical activity, and weight management under medical supervision. Common side effects include urinary tract infections, nasal congestion, pharyngitis, and upper respiratory infections. Adequate hydration is crucial to prevent dehydration. Genital yeast infections are a potential side effect; diligent hygiene helps mitigate this risk. Prior to commencing treatment, inform your doctor about any pre-existing kidney or liver conditions, urinary tract infections, or diuretic use. Pregnant or lactating individuals must seek medical advice before starting this medication. Limit alcohol consumption while using this medicine to minimize potential adverse effects. Regular blood glucose monitoring is essential during treatment.
Uses of Sitara-D 50/5 Tablet
Managing type 2 diabetes
Major Benefits of Sitara-D 50/5 Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Sitara-D 50/5 Tablets can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Sitara-D 50/5 Tablet:
- Vaginal yeast infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
- Upper respiratory tract infection
- Headache
How to use Sitara-D 50/5 Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Sitara-D 50/5 Tablets can be consumed with or without food, although consistent timing is recommended.
How Sitara-D 50/5 Tablet works:
Sitara-D 50/5 tablets combine two anti-diabetic agents. Dapagliflozin works by enhancing glucose elimination through urine, consequently lowering blood sugar. Sitagliptin's mechanism involves decreasing hepatic glucose production via elevated insulin and suppressed glucagon secretion, thus managing blood glucose.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Sitara-D 50/5 Tablet lacks established safety data. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Data on Sitara-D 50/5 Tablet use in pregnancy is absent. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Sitara-D 50/5 Tablet with breastfeeding is currently lacking. Seek medical advice from your physician.
DrivingCONSULT YOUR DOCTOR
Sitara-D 50/5 Tablet's effect on driving ability is undetermined. Refrain from driving if you exhibit symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Data on Sitara-D 50/5 Tablet use in individuals with renal impairment is scarce. Seek medical advice from your physician.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Sitara-D 50/5 Tablet's use in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Sitara-D 50/5 Tablet :
Should you forget to take a Sitara-D 50/5 Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication timetable. Avoid taking a double dose.
Facts to Know About Sitara-D 50/5 Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |


